Stem Cell Therapy for Liver Disease
肝病干细胞治疗
Duration
2-4 weeks for treatment course
Recovery
1-2 weeks post-procedure; liver function improvement over 3-6 months
Savings
~67% vs US
Average savings compared to US prices
Mesenchymal stem cell therapy for chronic liver diseases including cirrhosis, liver fibrosis, and liver failure. China's hepatology centers are global leaders in liver stem cell research, leveraging high patient volumes and advanced cell manufacturing facilities. Treatment aims to promote hepatocyte regeneration, reduce fibrosis, and improve liver function as a bridge to or alternative to transplantation.
Liver Function Assessment
Child-Pugh scoring, MELD calculation, FibroScan, MRI, and comprehensive hepatic panel
Duration: 2-3 daysCell Preparation
Allogeneic umbilical cord MSC or autologous bone marrow MSC preparation under GMP conditions
Duration: 1-2 weeksCell Delivery
Hepatic artery infusion or peripheral intravenous administration of stem cells
Duration: 1-3 sessions over 1-2 weeksPost-treatment Monitoring
Serial liver function tests, imaging follow-up, and fibrosis marker assessment
Duration: Monthly for 6-12 months- China has the largest clinical experience with liver stem cell therapy
- May improve liver function and reduce fibrosis progression
- Potential alternative for patients ineligible for transplantation
- Minimally invasive compared to surgical interventions
- Experimental treatment with variable outcomes
- Temporary fever and discomfort after cell infusion
- Not a proven substitute for liver transplantation in end-stage disease
- Portal hypertension may limit hepatic artery delivery
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.